Daniel Schultz to Drug Design
This is a "connection" page, showing publications Daniel Schultz has written about Drug Design.
Connection Strength
0.258
-
Carbohydrate-Small Molecule Hybrids as Lead Compounds Targeting IL-6 Signaling. Molecules. 2023 Jan 09; 28(2).
Score: 0.202
-
Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D4R Antagonists. ACS Chem Neurosci. 2024 Jun 19; 15(12):2396-2407.
Score: 0.056